Skip to main content

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 18, Number 11, April 2011

Articles

The Endocannabinoid System in the Cancer Therapy: An Overview
pp. 1575-1583(9)
Authors: Grimaldi, C.; Capasso, A.

Favourites:
ADD

Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions
pp. 1584-1598(15)
Authors: Labropoulou, V.T.; Theocharis, A.D.; Symeonidis, A.; Skandalis, S.S.; Karamanos, N.K.; Kalofonos, H.P.

Favourites:
ADD

Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
pp. 1599-1612(14)
Authors: Koutras, A.K.; Starakis, I.; Kyriakopoulou, U.; Katsaounis, P.; Nikolakopoulos, A.; Kalofonos, H.P.

Favourites:
ADD

Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations
pp. 1613-1628(16)
Authors: Pallis, A.; Briasoulis, E.; Linardou, H.; Papadimitriou, C.; Bafaloukos, D.; Kosmidis, P.; Murray, S.

Favourites:
ADD

Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer
pp. 1629-1639(11)
Authors: Pentheroudakis, G.; Stoyianni, A.

Favourites:
ADD

Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
pp. 1640-1650(11)
Authors: Petrelli, F.; Borgonovo, K.; Cabiddu, M.; Ghilardi, M.; Barni, S.

Favourites:
ADD

Targeted-Therapy in Advanced Renal Cell Carcinoma
pp. 1651-1657(7)
Authors: Pirrotta, M.T.; Bernardeschi, P.; Fiorentini, G.

Favourites:
ADD

Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
pp. 1658-1671(14)
Authors: Venugopal, B.; Evans, T.R.J.

Favourites:
ADD

Cinnamic Acid Derivatives as Anticancer Agents-A Review
pp. 1672-1703(32)
Authors: De, P.; Baltas, M.; Bedos-Belval, F.

Favourites:
ADD

Recent Advances in Studies on Hydroxamates as Matrix Metalloproteinase Inhibitors: A Review
pp. 1704-1722(19)
Authors: Yadav, R.K.; Gupta, S.P.; Sharma, P.K.; Patil, V.M.

Favourites:
ADD

Iron Regulation in Tuberculosis Research: Promise and Challenges
pp. 1723-1731(9)
Authors: Sharma, A.K.; Naithani, R.; Kumar, V.; Sandhu, S.S.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more